Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
John S. O'Brien, Director, Legislative Budget Board
SB409 by Janek (Relating to restrictions on the substitution of generically equivalent versions of antiepileptic and antiseizure drugs.), As Introduced
No significant fiscal implication to the State is anticipated.
The bill requires pharmacists to dispense the specific formulation, manufactured by the specific manufacturer, prescribed by a patient's physicians when the drugs are to be used for the treatment of epilepsy or the prevention of seizures; pharmacists may substitute a generically-equivalent drug product if the pharmacist obtains a signed authorization from the prescribing physician.
Local Government Impact
No fiscal implication to units of local government is anticipated.
515 Board of Pharmacy, 537 State Health Services, Department of, 539 Aging and Disability Services, Department of